Biology of aging brain

Indian Journal of Pathology and Microbiology

Volumn 53, Issue 4, 2010, Pages 595-604

  Shankar, S K ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Aging brain; calcium homeostasis; mitochondria; neurodegeneration; reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALCIUM; COLLAGEN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEAT SHOCK PROTEIN 73; IRON; LIPOFUSCIN;

AGING; ALZHEIMER DISEASE; ASTHENIA; ASTROCYTE; BRAIN BLOOD VESSEL; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN MICROCIRCULATION; BRAIN SIZE; BRAIN WEIGHT; CALCIUM HOMEOSTASIS; CELL SIZE; CEREBELLUM VERMIS; DEPRESSION; DOPAMINERGIC SYSTEM; ELASTIC FIBER; FRONTAL CORTEX; GENE EXPRESSION; GRAY MATTER; HIPPOCAMPUS; HUMAN; IMMEDIATE EARLY GENE; INSOMNIA; LEPTOMENINX; LEWY BODY; MICROGLIA; MOLECULAR MECHANICS; NERVE DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NONHUMAN; NORADRENERGIC SYSTEM; OCCIPITAL CORTEX; OSTEOPOROSIS; PARKINSON DISEASE; PREFRONTAL CORTEX; PYRAMIDAL NERVE CELL; REVIEW; SPATIAL MEMORY; SPINAL CORD INJURY; STROKE; SUBARACHNOID SPACE; SYNAPSE; TEMPORAL CORTEX; WEAKNESS; WORKING MEMORY;

AGING; ANIMALS; BRAIN; CALCIUM; COGNITION; HUMANS; MITOCHONDRIA; NEURONS; REACTIVE OXYGEN SPECIES; SYNAPSES;

EID: 78149367335     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.71995     Document Type: Review

References (124)

1. Available from: http://www.census.gov/egi-bin/ipc/idbagg-6/17/2008 [last accessed on 2010 Jan 5].
2. Capasso L, D'Anastasio R, Pierfelice L, Di Fabrizio A, Gallenga PE. Roman conquest, lifespan, and diseases in ancient Italy. Lancet 2003;23:362-668.
3. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science 2002;296:1029-31.
4. de Grey AD, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, et al. Time to talk SENS: Critiquing the immutability of human aging. Ann N Y Acad Sci 2002;959:452-62.
5. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006;12:7-12.
6. Terman A, Gustafsson B, Brunk UT. Autophagy, organelles and ageing. J Pathol 2007;211:134-43.
7. Brunk UT, Terman A. Is aging the price for memory? Biogerontology 2005;6:205-10.
8. Campisi J. Cancer and ageing: rival demons? Nat Rev Cancer 2003;3: 339-49.
9. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002;269:1996-2002.
10. Sohal RS, Sohal BH. Hydrogen peroxide release by mitochondria increases during aging. Mech Ageing Dev 1991;57:187-202.
11. White LR. Towards a program of cross-cultural research on the epidemiology of Alzheimer's disease. Curr Sci 1992;63:456-69.
12. Tiple P, Sharma SN, Srivastava AS. Psychiatric morbidity in geriatric people. Indian J Psychiatry 2006;48:88-94.
13. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. J Neuropathol Exp Neurol 1997;56:1269-75.
14. Anderton BH. Ageing of the brain. Mech Ageing Dev 2002;123:811-7.
15. Peters R. Ageing and the brain. Postgrad Med J 2006;82:84-8.
16. Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, et al. Sex differences in human brain morphometry and metabolism: An in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Arch Gen Psychiatry 1996;53:585-94.
17. Preston JE. Ageing choroid plexus-cerebrospinal fluid system Microsc Res Tech 2001;52:31-7.
18. Albeck MJ, Skak C, Nielsen PR, Olsen KS, Børgesen SE, Gjerris F. Age dependency of resistance to cerebrospinal fluid outflow. J Neurosurg 1998;89:275-8.
19. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D. Alzheimer's disease, normal-pressure hydrocephalus and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol 2003;2:506-11.
20. Moody DM, Brown WR, Challa VR, Anderson RL. Periventricular venous collagenosis: association with leukoaraiosis. Radiology 1995;194: 469-76.
21. Esiri MM. Which vascular lesions are of importance in vascular dementia? Ann N Y Acad Sci 2000;903:239-43.
22. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD. Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999;354:919-20.
23. Breteler MM. Vascular involvement in cognitive decline and dementia. Ann N Y Acad Sci 2000;903:457-65.
24. Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease. The CERAD experience, part XV. Neurology 1996;46:1592-6.
25. Weller RO, Yow HY, Preston SD, Mazanti I, Nicoll JA. Cerebrovascular disease is a major factor in the failure of limination of Abeta from the aging human brain: Implications for therapy of Alzheimer's disease. Ann N Y Acad Sci 2002;977:162-8.
26. Münch G, Cunningham AM, Riederer P, Braak E. Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Brain Res 1998;15:796:307-10.
27. Schultz C, Ghebremedhin E, Del Tredici K, Rüb U, Braak H. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe. Neurobiol Aging 2004;25:397-405.
28. Sheffield LG, Berman NE. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol Aging 1998;19:47-55.
29. Braak H. Spindle-shaped appendages of IIIab-pyramids filled with lipofuscin: a striking pathological change of the senescent human isocortex. Acta Neuropathologica 1979;46:197-202.
30. Brody H. The deposition of aging pigment in the human cerebral cortex. J Gerontol 1960;15:258-61.
31. Mann DM, Yates PO, Stamp JE. The relationship between lipofuscin pigment and ageing in the human nervous system. J Neurol Sci 1978;37:83-93.
32. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5: 863-73.
33. Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992;42:1681-8.
34. Giannakopoulos P, Hof PR, Mottier S, Michel JP, Bouras C. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 1994;87:456-68.
35. Sparks DL, Liu H, Scheff SW, Coyne CM, Hunsaker JC 3rd. Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals. J Neuropathol Exp Neurol 1993;52:135-42.
36. Yasha TC, Shankar L, Santosh V, Das S, Shankar SK. Histopathological and immunohistochemical evaluation of ageing changes in normal human brain. Indian J Med Res 1997;105:141-50.
37. Davies P. Neuronal abnormalities, not amyloid, are the cause of dementia in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer's disease. New York; Raven Press; 1994. p. 327-33.
38. Schmitt HP. Epsilon-Glycation, APP and A-beta in aging and Alzheimer's disease: a hypothesis. Medical Hypotheses 2006;66:898-906.
39. Buell SJ, Coleman PD. Dendritic growth in the aged human brain and failure of growth in senile dementia. Science 1979;206:854-6.
40. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nature Reviews/ Neuroscience 2006;7:30-40.
41. Launer LJ, Berger K, Breteler MM, Dufouil C, Fuhrer R, Giampaoli S, et al. Regional variability in the prevalence of cerebral white matter lesions: An MRI study in 9 European countries (CASCADE). Neuroepidemiology 2006;26:23-9.
42. Fernando MS, Ince PG. MRC Cognitive Function and Aging Neuropathology Study Group. Vascular pathologies and cognition in a population-based cohort of elderly people. J Neurol Sci 2004;226:13-7.
43. Simplson JE, Ince PG, Higham CE, Gelsthorpe CH, Fernando MS, Matthews F, et al. Cognitive Function and Ageing Neuropathology Study Group. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol App Neurobiol 2007;33:670-83.
44. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study. Neurology 2001;56:1539-45. (Pubitemid 32532267)
45. Dekaban AS. Changes in brain weights during the span of human life: Relations of brain weights to body heights and body weights. Ann Neurol 1978;4:345-56.
46. Coffey CE, Wilkinson WE, Parashos IA, Soady SA, Sullivan RJ, Patterson LJ, et al. Quantitative cerebral anatomy of the aging human brain: A cross-sectional study using magnetic resonance imaging. Neurology 1992;42:527-36.
47. Resnick SM, Pham D, Kraut MA, Zonderman AB, Davatzikos C. Longitudinal magnetic resonance imaging studies of older individuals: A selectively shrinking brain. J Neurosci 2003;23:3295-301.
48. Brody H. Organization of the cerebral cortex III: A study of aging in the human cerebral cortex. J Comp Neurol 1955;102:511-6.
49. Pakkenberg B, Gundersen HJ. Neocortical neuron number in humans: Effect of sex and age. J Comp Neurol 1997;384:312-20.
50. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal aging and Alzheimer's disease. Lancet 1994;344:769-72.
51. Keuker JI, Luiten PG, Fuchs E. Preservation of hippocampal neuron numbers in aged rhesus monkeys. Neurobiol Aging 2003;24:157-65.
52. Merrill DA, Chiba AA, Tuszyski MH. Conservation of neuronal number and size in the entorhinal cortex of behaviorally characterized aged rats. J Comp Neurol 2001;438:445-56.
53. Curcio CA, Hinds JW. Stability of synaptic density and spine volume in dentate gyrus of aged rats. Neurobiol Aging 1983;4:77-87.
54. Uemura E. Age-related changes in the subiculum of Macaca mulatta: Synaptic density. Exp Neurol 1985;87:403-11. (Pubitemid 15144752)
55. Smith DE, Rapp PR, McKay HM, Roberts JA, Tuszynski MH. Memory Impairment in Aged Primates is associated with focal death of cortical neurons and atrophy of subcortical neurons. J Neurosci 2004;24: 4373-81.
56. Spencer WD, Raz N. Differential effects of aging on memory for content and context: A meta-analysis. Psychol Aging 1995;10: 527-39.
57. McIntyre JS, Craik FI. Age differences in memory for item and source information. Can J Psychol 1987;41:175-92.
58. Rhodes MG. Age-related differences in performance on the Wisconsin Card Sorting Test: A meta-analytic review. Psychol Aging 2004;19: 482-94.
59. Cabeza R. Cognitive neuroscience of aging. Contributions of functional neuroimaging. Scand J Psychol 2001;42:277-86.
60. Cabeza R, Daselaar, SM, Dolcos F, Prince SE, Budde M, Nyberg L. Taskindependent and task-specific age effects on brain activity during working memory, visual attention and episodic retrieval. Cereb Cortex 2004;1:364-75.
61. Wilson MA, McNaughton BL. Dynamics of the hippocampal ensemble code for space. Science 1993;261:1055-8.
62. Barnes CA, Suster MS, Shen J, McNaughton BL. Multistability of cognitive maps in the hippocampus of old rats. Nature 1997;388:272-5.
63. Agnihotri NT, Hawkins RD, Kandel ER, Kentros C. The long-term stability of new protein synthesis. Proc Natl Acad Sci USA 2004;101:3656-61.
64. Dickstein DL, Kabaso D, Rocher AB, Luebke JI, Wearne SL, Hof PR. Changes in the structural complexity of the aged brain. Aging Cell 2007;6:275-84.
65. de Brabander JM, Kramers RJ, Uylings HB. Layer-specific dendritic regression of pyramidal cells with aging in human prefrontal cortex. Eur J Neurosci 1998;10:1261-9.
66. Hof PR, Morrison JH. The aging brain: Morphomolecular senescence of cortical circuits. Trends Neurosci 2004;27:607-13.
67. Mattson MP. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 1997;77:1081-132.
68. Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000;1:120-9.
69. Mattson MP, Chan SL, Duan W. Modification of brain aging and neurodegenerative disorders by genes,diet and behavior. Physiol Rev 2002;82:637-72.
70. van Root JM. Stress proteins in CNS inflammation. J Pathol 2008;214:267-75.
71. Richter-Landsberg C, Goldbaum O. Stress proteins in neural cells: Functional roles in health and disease. Cell Mol Life Sci 2003;60:337-49.
72. Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, et al. Chaperones increase association of tau protein with microtubules. Proc Nat Acad Sci USA 2003;100:721-6.
73. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, Hartl, FU. Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid like fibrils. Proc Natl Acad Sci USA 2000;97:7841-6.
74. Papazoglu C, Mills AA. p53: At the crossroad between cancer and ageing. J Pathol 2007;211:124-33.
75. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat Rev Mol Cell Biol 2003;4:552-65.
76. Berridge MJ, Bootman LP. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 2000;1:11-21.
77. Ghosh A, Ginty DD, Bading H, Greenberg ME. Calcium regulation of gene expression in neuronal cells. J Neurobiol 1994;25:294-303.
78. Duchen MR. Mitochondria and calcium: from cell signalling to cell death. J Physiol 2000;529:57-68.
79. Solovyova N, Veselovsky N, Toescu EC, Verkhratsky A. Ca2+ dynamics in the lumen of the endoplasmic reticulum in sensory neurons: Direct visualization of Ca(2+) induced Ca(2+) release triggered by physiological Ca(2+) entry. EMBO J 2002;21:622-30.
80. Murchison D, Griffith WH. Calcium buffering systems and calcium signaling in aged rat basal forebrain neurons. Aging Cell 2007;6: 297-305.
81. Ouda L, Druga R, Syka J. Changes in parvalbumin immunoreactivity with aging in the central auditory system of the rat. Exp Gerontol 2008;43:782-9.
82. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O. Chronic 1alpha, 25-(OH)2 vitamin D3 treatment reduces Ca2+ mediated hippocampal biomarkers of aging. Cell Calcium 2006;40:277-86.
83. Gomez-Villafuertes R, Mellström B, Naranjo JR. Searching for a role of NCX/NCKX exchangers in neurodegeneration. Mol Neurobiol 2007;35:195-202.
84. Buchholz JN. Vanterpool CK, Pearce WJ. Age dependent changes in Ca2+ homeostasis in peripheral neurones: implications for changes in function. Aging Cell 2007;6:285-96.
85. Toescu EC, Verkhratsky A. Ca2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J Cell Mol Med 2004;8:181-90.
86. Toescu EC. Normal brain ageing: models and mechanisms. Philos Trans R Soc Lond B Biol Sci 2005;360:2347-54.
87. Sastre J, Pallardo FV, Vina J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med 2003;35:1-8.
88. Kumar A, Bodhinathan K, Foster T. Cell selective susceptibility to calcium dysregulation during brain aging. Front Aging Neurosci 2009;1:2.
89. Rehman HU, Masson EA. Neuroendocrinology of ageing. Age Ageing 2001;30:279-87.
90. Greenwald SE. Ageing of the conduit arteries. J Pathol 2007;211:157-72.
91. O'Rourke MF. Pulsatile arterial haemodynamics in hypertension. Aust N Z J Med 1976;6:40-8.
92. Li Z, Froehlich J, Galis ZS. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 1999;33:116-23.
93. Aronson D. Cross-linking of glycated collagen in the pathgenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens 2003;21:3-12.
94. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.
95. Bartzokis G, Cummings JL, Sultzer D, Henderson VW, Nuechterlein KH, Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer's disease. Arch Neurol 2003;60:393-8.
96. Barker W, Luis C, Kashuba A. Relative frequencies of Alzheimer's disease, Lewy body, vascular and fronto temporal dementia and hippocampal sclerosis in the state of Florida Brain Bank. Alzheimer Dis Asso Disord 2002;16:203-12.
97. Sparks D, Scheff S, Liu H, Landers T, Coyne C, Hunsacker J. Increased incidence of neurofibrillary tangles (NFT) in nondemented individuals with hypertension. J Neurol Sci 1995;131:162-9.
98. Jellinger KA. Alzheimer's disease and cerebrovascular pathology: An update. J Neurol Trans 2002;109:813-36.
99. Cole A J, Saffen DW, Baraban JM, Worley PF. Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation. Nature 1989;340:474-6.
100. Reti IM, Reddy R, Worley PF, Baraban JM. Prominent Narp expression in projection pathways and terminal fields. J Neurochem 2002;82:935-44.
101. O'Brien RJ, Xu D, Petralia RS, Steward O, Huganir RL, Worley P. Synaptic clustering of AMPA receptors by the extracellular immediate early gene product Narp. Neuron 1999;23:309-23.
102. Steward O, Wallace CS, Lyford GL, Worley PF. Synaptic activation causes the mRNA for the IEG Arc to localize selectively near activated post synaptic sites on dendrites. Neuron 1998;21:741-51.
103. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 2003;23:3807-19.
104. Saunders AM. Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses. J Neuropathol Exp Neurol 2000;59:751-8.
105. Deary IJ, Whiteman MC, Pattie A, Starr JM, Hayward C, Wright AF, et al. Apolipoprotein E gene variability and cognitive functions at age 79: A follow-up of the scottish mental survey of 1992. Psychol Aging 2004;19:367-71.
106. Brown DR. Prion protein expression aids cellular uptake and veratridine-induced release of copper. J Neurosci Res 1999;58:717-25.
107. Kachiwala SJ, Harris SE, Wright AF, Hayward C, Starr JM, Whalley LJ, et al. Genetic influences on oxidative stress and their association with normal cognitive ageing. Neurosci Lett 2005;386:116-20.
108. Wolkow CA. Life span: Getting the signal from the nervous system. Trends Neurosci 2002;25:212-6.
109. Mattson MP. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2003;2:329-42.
110. Kyng KJ, Bohr VA. Gene expression and DNA repair in progeroid syndromes and human aging. Ageing Res Rev 2005;4:579-602.
111. Harper ME, Monemdjou S, Ramsey JJ, Weindruch R. Age-related increase in mitochondrial proton leak and decrease in ATP turnover reactions in mouse hepatocytes. Am J Physiol 1998;275:197-206.
112. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol Rev 2000;80:315-60.
113. Stadtman ER. Protein oxidation and aging. Free Rad Res 2006;40: 1250-8.
114. Keller JN, Pang Z, Geddes JW, Begley JG, Germeyer A, Waeg G, et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta - peptide: role of lipid peroxidation product 4 - hydroxynoneal. J Neurochem 1997;69:273-84.
115. Shay JW, Wright WE. Hallmarks of telomeres in ageing research. J Pathology 2007;211:114-23.
116. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52.
117. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative lifespan. Curr Biol 1998;8:279-82.
118. Oikawa S, Kawanishi S. Site-specific DNA damage at GGG sequence by oxidative stress may accelerate telomere shortening. FEBS Lett 1999;453:365-8.
119. Kanazawa I. How do neurons die in neurodegenerative diseases? Trends Mol Med 2001;8:339-44.
120. Luthi-Carter R, Kama JA, Dunah, Young SJ, Cha AB, Olson JM. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum Mol Genet 2000;9:1259-71.
121. Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patient with Parkinson's disease. Brain Res 1993;606:341-5.
122. Schenk D, Barbour R, Dunn W. Immunization with amyloid-ß attenuates Alzheimer's disease like pathology in the PDAPP mouse. Nature 1999;400:173-7.
123. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, et al. Abeta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 2000;408:982-5.
124. Ferrer I, Rovira MB, Sanchez Guerra ML. Neuropathology and pathogenesis of encephalitis following Amyloid-β immunization in Alzheimer's disease. Path Lab Med 2004;14:11-20.